| 2024-08-06 | +35.2% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2024-02-27 | -32.3% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2023-02-23 | -30.9% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2021-08-04 | -23.0% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2024-01-05 | +22.7% | legal | SEC EDGAR | INGN 8-K: 5.02 (SEC Filing) |
| 2021-08-05 | -22.7% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2025-08-08 | +19.4% | earnings | Seeking Alpha | Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript |
| 2025-08-08 | +19.4% | earnings | TradingView | Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y - TradingView |
| 2025-02-25 | -17.1% | earnings | Seeking Alpha | Inogen, Inc. 2024 Q4 - Results - Earnings Call Presentation |
| 2025-02-25 | -17.1% | earnings | Seeking Alpha | Inogen GAAP EPS of -$0.41 beats by $0.20, revenue of $80.1M beats by $6.2M |
| 2025-02-25 | -17.1% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2023-07-13 | -15.8% | legal | SEC EDGAR | INGN 8-K: 1.01, 2.02, 7.01 (SEC Filing) |
| 2023-08-07 | -15.1% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2025-02-26 | -14.9% | earnings | Seeking Alpha | Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript |
| 2024-11-07 | +14.7% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2024-11-07 | +14.7% | news | Yahoo Finance | Inogen, Inc. (INGN): A Bear Case Theory - Yahoo Finance |
| 2024-05-07 | +14.5% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2025-05-08 | -13.5% | earnings | Seeking Alpha | Inogen targets $352M-$355M in 2025 revenue with focus on B2B growth and strategic innovations |
| 2025-05-08 | -13.5% | earnings | Seeking Alpha | Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript |
| 2025-11-05 | -12.0% | earnings | Seeking Alpha | Inogen reiterates $354M–$357M 2025 revenue guidance as international B2B grows 19% while expanding innovation pipeline |
| 2025-11-05 | -12.0% | earnings | Seeking Alpha | Inogen, Inc. (INGN) Q3 2025 Earnings Call Transcript |
| 2025-11-05 | -12.0% | earnings | Seeking Alpha | Inogen, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-05 | -12.0% | earnings | Seeking Alpha | Inogen Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $92.39M beats by $0.19M |
| 2025-11-05 | -12.0% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2023-06-06 | +11.6% | legal | SEC EDGAR | INGN 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-01-12 | -11.5% | earnings | Seeking Alpha | Inogen sees Q4 net sales of $82M and $349M for the full-year 2025 |
| 2026-01-12 | -11.5% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2023-11-13 | +11.4% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-07 | -11.3% | earnings | Seeking Alpha | Inogen reports Q1 results |
| 2025-05-07 | -11.3% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2025-01-13 | +10.9% | earnings | Seeking Alpha | Inogen expects prelim Q4 revenue in the range of $79M to $80M |
| 2025-01-13 | +10.9% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2026-02-25 | +10.0% | earnings | Seeking Alpha | Inogen outlines path to 6% revenue growth in 2026 while launching $30M share repurchase program |
| 2026-02-25 | +10.0% | earnings | Seeking Alpha | Inogen, Inc. (INGN) Q4 2025 Earnings Call Transcript |
| 2026-02-25 | +10.0% | earnings | ChartMill | Inogen Inc (NASDAQ:INGN) Stock Falls on Revenue Miss and Cautious 2026 Outlook - ChartMill |
| 2025-11-04 | -9.1% | earnings | Seeking Alpha | Inogen Q3 2025 Earnings Preview |
| 2022-11-02 | -9.0% | legal | SEC EDGAR | INGN 8-K: 2.02, 5.03 (SEC Filing) |
| 2026-04-06 | +9.0% | executive | Business Wire | Inogen Announces the Appointment of Vafa Jamali to Board of Directors |
| 2026-04-06 | +9.0% | legal | SEC EDGAR | INGN 8-K: 1.01, 5.02, 7.01 (SEC Filing) |
| 2026-04-06 | +9.0% | news | Stock Titan | A $3 billion medtech veteran joins Inogen's board under Kent Lake pact - Stock Titan |
| 2026-04-06 | +9.0% | expansion | Stock Titan | Inogen (Nasdaq: INGN) names Vafa Jamali director and signs cooperation agreement - Stock Titan |
| 2026-04-06 | +9.0% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Inogen (INGN) Stock Near Resistance | Price at $6.36, Up 2.42% - Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La |
| 2022-02-24 | +8.8% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2023-07-18 | -8.8% | legal | SEC EDGAR | INGN 8-K: 1.01 and (SEC Filing) |
| 2026-04-16 | +8.5% | executive | MarketBeat | Inogen Unveils Growth Plan at Needham Conference: New CFO, Voxi 5, Simeox and Aurora Mask Push |
| 2024-12-30 | +8.4% | legal | SEC EDGAR | INGN 8-K: 7.01, 8.01 (SEC Filing) |
| 2022-08-01 | +8.0% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Inogen (INGN) - Zacks Investment Research |
| 2025-08-06 | -7.9% | earnings | Seeking Alpha | Inogen Q2 2025 Earnings Preview |
| 2023-05-04 | -7.3% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2021-11-04 | -6.8% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2022-08-04 | -6.7% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2026-01-07 | +6.7% | news | Stock Titan | New CPAP masks offer quieter nights for people with sleep apnea - Stock Titan |
| 2024-07-03 | +6.5% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-07-22 | +6.1% | earnings | Seeking Alpha | Inogen: Earnings Uncertainty Weakens Valuation Argument (Rating Downgrade) |
| 2025-07-22 | +6.1% | earnings | Seeking Alpha | Inogen: Earnings Uncertainty Weakens Valuation Argument (Rating Downgrade) - Seeking Alpha |
| 2024-03-26 | +5.3% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-04-08 | -5.2% | news | Zacks | Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains? |
| 2026-04-08 | -5.2% | executive | Stock Titan | Inogen (INGN) grants CFO 100,000 RSUs with multi-year vesting - Stock Titan |
| 2026-04-08 | -5.2% | executive | Stock Titan | Inogen Inc (INGN) EVP & CFO Jason Richardson listed in new Form 3 filing - Stock Titan |
| 2022-01-10 | -5.0% | legal | SEC EDGAR | INGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-08 | -4.6% | expansion | Yahoo Finance | INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite - Yahoo Finance |
| 2024-04-15 | -4.4% | legal | SEC EDGAR | INGN 8-K: 5.02 (SEC Filing) |
| 2026-02-24 | +4.2% | earnings | Seeking Alpha | Inogen, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-24 | +4.2% | earnings | Seeking Alpha | Inogen GAAP EPS of -$0.26 beats by $0.09, revenue of $81.7M misses by $0.3M |
| 2026-02-24 | +4.2% | news | Seeking Alpha | Inogen authorizes $30M share repurchase program; shares up |
| 2026-02-24 | +4.2% | legal | SEC EDGAR | INGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-24 | +4.2% | earnings | Stock Titan | No-debt device maker Inogen eyes up to $373M in 2026 revenue - Stock Titan |
| 2026-02-24 | +4.2% | earnings | Investing.com | Inogen Inc earnings beat by $0.07, revenue fell short of estimates - Investing.com |
| 2026-02-24 | +4.2% | news | GuruFocus | Inogen (INGN) Initiates $30 Million Share Buyback Program - GuruFocus |
| 2026-01-15 | -4.0% | news | simplywall.st | Inogen (NASDAQ:INGN shareholders incur further losses as stock declines 11% this week, taking five-year losses to 86% - simplywall.st |
| 2021-12-13 | -4.0% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-27 | -4.0% | news | Stock Titan | Vanguard disaggregates holdings; INGN shows 0 shares (INGN) - Stock Titan |
| 2023-11-27 | -3.9% | legal | SEC EDGAR | INGN 8-K: 5.02 and (SEC Filing) |
| 2025-01-27 | +3.9% | news | Seeking Alpha | Inogen partners with Yuwell to expand product portfolio, accelerate entry into Chinese market |
| 2025-01-27 | +3.9% | legal | SEC EDGAR | INGN 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2021-07-29 | +3.8% | legal | SEC EDGAR | INGN 8-K: 5.02 (SEC Filing) |
| 2025-06-16 | +3.6% | news | Seeking Alpha | Inogen: Still Breathing, But Margin Pressures Persist |
| 2025-06-16 | +3.6% | news | Seeking Alpha | Inogen: Still Breathing, But Margin Pressures Persist (NASDAQ:INGN) - Seeking Alpha |
| 2023-03-22 | -3.4% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-06 | +3.3% | earnings | Seeking Alpha | Inogen Q1 2025 Earnings Preview |
| 2022-03-23 | -3.3% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-19 | +3.2% | legal | SEC EDGAR | INGN 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-07-29 | -3.1% | legal | SEC EDGAR | INGN 8-K: 5.02 (SEC Filing) |
| 2025-05-30 | -3.1% | news | Yahoo Finance | With 72% ownership of the shares, Inogen, Inc. (NASDAQ:INGN) is heavily dominated by institutional owners - Yahoo Finance |
| 2025-02-24 | -3.0% | earnings | Seeking Alpha | Inogen Q4 2024 Earnings Preview |
| 2021-05-04 | -2.9% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2026-04-15 | +2.9% | news | Cổng thông tin điện tử Tỉnh Sơn La | Inogen (INGN) Stock: Macro Opportunities (Technical Weakness) 2026-04-15 - Gap Down Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-03-30 | -2.7% | news | Business Wire | Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-03-30 | -2.7% | executive | Business Wire | Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth |
| 2026-03-30 | -2.7% | executive | Seeking Alpha | Inogen appoints new CFO |
| 2026-03-30 | -2.7% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-30 | -2.7% | news | Business Wire | Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire |
| 2026-03-30 | -2.7% | earnings | Stock Titan | Inogen taps three executives, including a new CFO, and keeps outlook - Stock Titan |
| 2026-03-30 | -2.7% | executive | Stock Titan | Inogen (NASDAQ: INGN) appoints new CFO and growth-focused commercial leaders - Stock Titan |
| 2023-09-18 | -2.7% | legal | SEC EDGAR | INGN 8-K: 2.01, 7.01 (SEC Filing) |
| 2026-04-21 | +2.5% | earnings | Zacks | Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates |
| 2023-07-31 | -2.5% | legal | SEC EDGAR | INGN 8-K: 5.02 (SEC Filing) |
| 2025-02-03 | +2.3% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-03 | +2.3% | news | Stock Titan | Inogen (INGN) EVP Kevin P. Smith reports RSU grants and tax share withholding - Stock Titan |
| 2026-04-07 | +2.3% | news | GlobeNewswire | Global Anesthesia and Respiratory Devices Market Size/Share Worth USD 100.5 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) |
| 2026-04-07 | +2.3% | news | Yahoo Finance | Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains? - Yahoo Finance |
| 2025-08-07 | +2.2% | earnings | Seeking Alpha | Inogen GAAP EPS of -$0.15 beats by $0.12, revenue of $92.28M beats by $1.68M |
| 2025-08-07 | +2.2% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2025-08-31 | +2.1% | earnings | simplywall.st | There's No Escaping Inogen, Inc.'s (NASDAQ:INGN) Muted Revenues Despite A 29% Share Price Rise - simplywall.st |
| 2024-01-24 | +2.1% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-05-05 | +1.9% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2022-01-28 | -1.8% | legal | SEC EDGAR | INGN 8-K: 5.02 (SEC Filing) |
| 2026-04-23 | -1.8% | news | Business Wire | Inogen to Report First Quarter 2026 Financial Results on May 7, 2026 |
| 2026-04-23 | -1.8% | earnings | Stock Titan | Inogen sets May 7 earnings call; webcast archive stays up 6 months - Stock Titan |
| 2023-11-07 | -1.7% | legal | SEC EDGAR | INGN 8-K: 2.02 and (SEC Filing) |
| 2025-10-08 | -1.4% | news | TradingKey | INGN|Inogen Inc|Price:7.060|Chg%:0.07 - TradingKey |
| 2023-01-10 | +1.2% | legal | SEC EDGAR | INGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-02 | +1.2% | news | Yahoo Finance | Here's Why You Should Add Inogen Stock to Your Portfolio Now - Yahoo Finance |
| 2026-02-23 | +1.2% | earnings | Seeking Alpha | Inogen Q4 2025 Earnings Preview |
| 2021-12-30 | +1.1% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-31 | -1.1% | news | Business Wire | Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference |
| 2026-03-31 | -1.1% | executive | Stock Titan | Inogen CEO to speak April 14 at Needham healthcare event - Stock Titan |
| 2024-07-31 | -1.1% | legal | SEC EDGAR | INGN 8-K: 5.02 and (SEC Filing) |
| 2023-02-10 | -1.0% | legal | SEC EDGAR | INGN 8-K: 5.02 and (SEC Filing) |
| 2026-03-28 | -1.0% | analyst | Cổng thông tin điện tử Tỉnh Sơn La | Is Inogen (INGN) Stock a Market Leader | Price at $6.39, Up 0.95% - Verified Analyst Reports - Cổng thông tin điện tử Tỉnh Sơn La |
| 2024-06-07 | -0.8% | legal | SEC EDGAR | INGN 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-11-11 | +0.7% | news | Seeking Alpha | Slow Progress At Inogen ... But Progress All The Same |
| 2025-11-11 | +0.7% | news | Seeking Alpha | Slow Progress At Inogen … But Progress All The Same (NASDAQ:INGN) - Seeking Alpha |
| 2024-05-15 | -0.7% | legal | SEC EDGAR | INGN 8-K: 5.02 and (SEC Filing) |
| 2022-04-19 | -0.7% | legal | SEC EDGAR | INGN 8-K: 5.02 (SEC Filing) |
| 2025-03-01 | -0.6% | news | Seeking Alpha | A Volatile Share Price Masks Some Of The Progress At Inogen |
| 2022-02-22 | -0.6% | legal | SEC EDGAR | INGN 8-K: 5.02 (SEC Filing) |
| 2026-02-17 | +0.5% | earnings | Finviz | Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Finviz |
| 2022-03-04 | -0.5% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-05-24 | -0.4% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-22 | -0.2% | news | Zacks | Here's Why You Should Retain Inogen Stock in Your Portfolio for Now |
| 2026-04-22 | -0.2% | news | TradingView | Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - TradingView |
| 2023-08-11 | +0.2% | legal | SEC EDGAR | INGN 8-K: 5.02 and (SEC Filing) |
| 2023-09-07 | -0.0% | legal | SEC EDGAR | INGN 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-24 | — | earnings | MarketBeat | Inogen (NASDAQ:INGN) Stock Price Passes Above 50 Day Moving Average - Here's What Happened - MarketBeat |